An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer

Author:

Liu Jiaxuan,Wang Ping,Zhang Ping,Zhang Xinyu,Du Hang,Liu Qiang,Huang Bo,Qian Caiyun,Zhang Shuhua,Zhu Weifeng,Yang Xiaohong,Xiao Yingqun,Liu Zhuoqi,Luo DayaORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Reference73 articles.

1. Agarwal V, Bell G, Nam J, Bartel D (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4. https://doi.org/10.7554/eLife.05005

2. Ambros VR (2004) The functions of animal microRNAs. Nature 431:350–355

3. Avril N et al (2001) Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 42:9–16

4. Bar I, Merhi A, Abdelsater F, Ben AA, Sollennita S, Canon JL, Delrée P (2017) The MicroRNA miR-210 is expressed by cancer cells but also by the tumor microenvironment in triple-negative breast cancer. J Histochem Cytochem 65:22155417702849

5. Barrett T et al (2013) NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res 41:991–995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3